Treatment of Gram-negative folliculitis with 13-cis-retinoic acid. (Record no. 6954652)

MARC details
000 -LEADER
fixed length control field 00812 a2200253 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513001920.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198210s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0007-0963
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Jones, D H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19821021
245 00 - TITLE STATEMENT
Title Treatment of Gram-negative folliculitis with 13-cis-retinoic acid.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The British journal of dermatology
Date of publication, distribution, etc. Aug 1982
300 ## - PHYSICAL DESCRIPTION
Extent 252-3 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bacterial Infections
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Folliculitis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isotretinoin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tretinoin
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cunliffe, W J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name King, K
773 0# - HOST ITEM ENTRY
Title The British journal of dermatology
Related parts vol. 107
-- no. 2
-- p. 252-3

No items available.